Could a simple blood test predict lupus in children with ITP?

NCT ID NCT07680010

Not yet recruiting Knowledge-focused Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

First seen Jul 01, 2026 · Last updated Jul 17, 2026 · Updated 3 times

Summary

This study looks at children with immune thrombocytopenic purpura (ITP) who also have certain antibodies, as they are at higher risk of developing lupus. Researchers will analyze blood samples to track immune cell changes and markers that may signal the transition to lupus. The goal is to better understand how lupus begins and find ways to prevent it in the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could reveal early warning signs of lupus in children with ITP, pointing toward ways to prevent lupus before it starts.
What could go wrong: This is an observational study, not a treatment trial. It may not lead to immediate prevention strategies, and findings may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMMUNE THROMBOCYTOPENIC PURPURA (ITP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autoimmune thrombocytopenic purpura Purpura, Thrombocytopenic, Idiopathic systemic lupus erythematosus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IMMUNE THROMBOCYTOPENIC PURPURA (ITP) SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Contacts and locations

Locations

CHU Toulouse - Hôpital des Enfants

Toulouse, 31026, France
Chu de Bordeaux- Groupe Hospitalier Pellegrin - Hôpital des Enfants

Bordeaux, 33076, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.